Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The effects of neurotrophins and the neuropeptides VIP and PACAP on HIV-1 infection: histories with opposite ends.

Souza TM, Temerozo JR, Giestal-de-Araujo E, Bou-Habib DC.

Neuroimmunomodulation. 2014;21(5):268-82. doi: 10.1159/000357434. Epub 2014 Mar 1. Review.

2.

Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP.

Temerozo JR, Joaquim R, Regis EG, Savino W, Bou-Habib DC.

PLoS One. 2013 Jun 20;8(6):e67701. doi: 10.1371/journal.pone.0067701. Print 2013.

3.
4.

Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.

Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.

J Endocrinol. 2008 Feb;196(2):291-303. doi: 10.1677/JOE-07-0127.

6.

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.

Ganea D, Rodriguez R, Delgado M.

Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):127-42. Review.

PMID:
12887096
8.
9.

Comparison between vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide levels in neuroblastoma tumour tissues.

Vertongen P, De Clerck P, Fournet JC, Martelli H, Hélardot P, Devalck C, Peeters T, Sariban E, Robberecht P.

Neuropeptides. 1997 Oct;31(5):409-13.

PMID:
9413016
10.
11.

PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.

Girard BM, Malley SE, Braas KM, May V, Vizzard MA.

J Mol Neurosci. 2010 Nov;42(3):378-89. doi: 10.1007/s12031-010-9384-3. Epub 2010 May 7.

12.

Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

Gonzalez-Rey E, Varela N, Chorny A, Delgado M.

Curr Pharm Des. 2007;13(11):1113-39. Review.

PMID:
17430175
13.

PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.

Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J.

Neuropeptides. 2014 Apr;48(2):53-64. doi: 10.1016/j.npep.2014.01.004. Epub 2014 Jan 25.

PMID:
24508136
14.

Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.

Leceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M.

Ann N Y Acad Sci. 2000;921:92-102.

PMID:
11193883
16.

Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.

Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pévet P.

Neuroscience. 1998 Aug;85(3):887-96.

PMID:
9639281
19.

Supplemental Content

Support Center